| Literature DB >> 17785204 |
Ping Gao1, Huafeng Zhang, Ramani Dinavahi, Feng Li, Yan Xiang, Venu Raman, Zaver M Bhujwalla, Dean W Felsher, Linzhao Cheng, Jonathan Pevsner, Linda A Lee, Gregg L Semenza, Chi V Dang.
Abstract
The antitumorigenic activity of antioxidants has been presumed to arise from their ability to squelch DNA damage and genomic instability mediated by reactive oxygen species (ROS). Here, we report that antioxidants inhibited three tumorigenic models in vivo. Inhibition of a MYC-dependent human B lymphoma model was unassociated with genomic instability but was linked to diminished hypoxia-inducible factor (HIF)-1 levels in a prolyl hydroxylase 2 and von Hippel-Lindau protein-dependent manner. Ectopic expression of an oxygen-independent, stabilized HIF-1 mutant rescued lymphoma xenografts from inhibition by two antioxidants: N-acetylcysteine and vitamin C. These findings challenge the paradigm that antioxidants diminish tumorigenesis primarily through decreasing DNA damage and mutations and provide significant support for a key antitumorigenic effect of diminishing HIF levels.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17785204 PMCID: PMC2084208 DOI: 10.1016/j.ccr.2007.08.004
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743